Vanda Pharmaceuticals
VNDA
#7650
Rank
A$0.44 B
Marketcap
$7.64
Share price
3.24%
Change (1 day)
30.80%
Change (1 year)

Earnings for Vanda Pharmaceuticals (VNDA)

Earnings in 2024 (TTM): -A$55.65 Million

According to Vanda Pharmaceuticals's latest financial reports the company's current earnings are A$0.19 Billion. In 2023 the company made an earning of -A$22.29 Million a decrease over its 2022 earnings that were of A$10.1 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Vanda Pharmaceuticals from 2005 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) -A$55.65 Million149.67%
2023 -A$22.29 Million-320.45%
2022 A$10.1 M-84.99%
2021 A$67.35 M54.8%
2020 A$43.51 M19.42%
2019 A$36.43 M4.93%
2018 A$34.72 M-228.6%
2017 -A$27.01 Million-8.98%
2016 -A$29.67 Million-53.79%
2015 -A$64.19 Million-30.18%
2014 -A$91.94 Million173.08%
2013 -A$33.67 Million-25.33%
2012 -A$45.09 Million163.61%
2011 -A$17.11 Million-221.15%
2010 A$14.11 M-124.53%
2009 -A$57.56 Million-29.44%
2008 -A$81.57 Million-36.2%
2007 -A$0.13 Billion21.81%
2006 -A$0.11 Billion170.55%
2005 -A$38.8 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
A$20.33 B-34,074.65%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
A$16.21 B-27,186.06%๐Ÿ‡บ๐Ÿ‡ธ USA
A$29.38 B-49,186.06%๐Ÿ‡บ๐Ÿ‡ธ USA
-A$10.99 Billion 18,258.91%๐Ÿ‡บ๐Ÿ‡ธ USA
A$11.09 B-18,627.02%๐Ÿ‡บ๐Ÿ‡ธ USA
-A$8.73 Million-85.43%๐Ÿ‡บ๐Ÿ‡ธ USA
A$23.91 B-40,054.64%๐Ÿ‡บ๐Ÿ‡ธ USA